David Elkins V.
Chief Financial Officer, Becton Dickinson.
Companies
- Tapestry, Inc.Board member Mar 1, 2024 to now1
- Bristol-Myers SquibbChief financial officer Nov 27, 2019 to now2
- Becton DickinsonChief financial officer Dec 11, 2008 to Nov 13, 20123
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Bristol-Myers Squibb BMY159,542 shares4$9.7M at $60.95Apr 2, 2026
Tapestry, Inc. TPR7,347 shares5$863.7K at $117.56Nov 13, 2025
Becton Dickinson BDX0 shares6Nov 9, 2012
As of each latest filing. The line shows shares held over time.
Recent filings
- Apr 1, 2026Sold 4,481 shares at $62.05 of Bristol-Myers Squibb4
- Apr 1, 2026Sold 25,519 shares at $61.60 of Bristol-Myers Squibb4
- Mar 10, 2026Shares withheld for tax 10,240 shares at $60.13 of Bristol-Myers Squibb7
- Mar 10, 2026Other 23,285 shares of Bristol-Myers Squibb7
- Mar 10, 2026Exercised options 47,424 shares of Bristol-Myers Squibb7
- Mar 10, 2026Shares withheld for tax 2,991 shares at $60.13 of Bristol-Myers Squibb7
- Mar 10, 2026Other 854 shares of Bristol-Myers Squibb7
- Mar 10, 2026Exercised options 7,904 shares of Bristol-Myers Squibb7
- Mar 10, 2026Shares withheld for tax 2,883 shares at $60.13 of Bristol-Myers Squibb7
- Mar 10, 2026Other 860 shares of Bristol-Myers Squibb7
- Mar 10, 2026Exercised options 7,654 shares of Bristol-Myers Squibb7
- Nov 13, 2025Granted 1,985 shares at $100.76 of Tapestry, Inc.5
- Sep 2, 2025Sold 56,000 shares at $47.33 of Bristol-Myers Squibb8
- Mar 10, 2025Shares withheld for tax 12,295 shares at $63.11 of Bristol-Myers Squibb9
- Mar 10, 2025Other 16,934 shares of Bristol-Myers Squibb9
- Mar 10, 2025Exercised options 45,916 shares of Bristol-Myers Squibb9
- Mar 10, 2025Shares withheld for tax 2,782 shares at $63.11 of Bristol-Myers Squibb9
- Mar 10, 2025Other 1,347 shares of Bristol-Myers Squibb9
- Mar 10, 2025Exercised options 7,904 shares of Bristol-Myers Squibb9
- Mar 10, 2025Shares withheld for tax 2,680 shares at $63.11 of Bristol-Myers Squibb9
- Mar 10, 2025Other 1,335 shares of Bristol-Myers Squibb9
- Mar 10, 2025Exercised options 7,652 shares of Bristol-Myers Squibb9
- Mar 10, 2025Shares withheld for tax 3,178 shares at $63.11 of Bristol-Myers Squibb9
- Mar 10, 2025Other 555 shares of Bristol-Myers Squibb9
- Mar 10, 2025Exercised options 8,045 shares of Bristol-Myers Squibb9
Trade performance
| Date | Stock | Trade | Value | Return since | Vs S&P since | Vs S&P, 1 year |
|---|---|---|---|---|---|---|
| Apr 1, 2026 | BMY | Sale | $1.9M | −3.2% | +21.0% | |
| Sep 2, 2025 | BMY | Sale | $2.7M | +26.0% | −5.5% | −23.2% |
| Sep 13, 2022 | BMY | Sale | $9.6M | −15.9% | +112.2% | +29.6% |
| Aug 12, 2021 | BMY | Sale | $6.7M | −10.8% | +84.1% | −16.9% |
Returns are price-only (no dividends), measured from the trade date.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARTapestry, Inc., Board member
- 2
- 3
- 4
- 5
- 6
- 7SEC EDGARForm 4 filed Mar 12, 2026
- 8SEC EDGARForm 4 filed Sep 3, 2025
- 9SEC EDGARForm 4 filed Mar 12, 2025